Status:

COMPLETED

Role of Leptin in the Neuroendocrine and Immune Response to Fasting

Lead Sponsor:

Beth Israel Deaconess Medical Center

Collaborating Sponsors:

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

National Center for Research Resources (NCRR)

Conditions:

Fasting

Eligibility:

All Genders

18-30 years

Phase:

PHASE1

PHASE2

Brief Summary

The purpose of this study will be to determine whether giving leptin (r-metHuLeptin) to a person when he or she is fasting will reverse changes in metabolism, and hormone levels, and immune function a...

Detailed Description

Leptin is a hormone secreted by fat cells under normal conditions and acts in the brain to decrease appetite and increase energy use. Leptin levels usually go down with fasting. This study will evalua...

Eligibility Criteria

Inclusion

  • Healthy lean women (with body mass indices \[BMI\] \< 25 kg/m2)
  • Overweight otherwise healthy men (with BMI \> 27 kg/m2)
  • Overweight otherwise healthy women (with BMI \> 27 kg/m2).

Exclusion

  • A history of any illness that may affect the concentrations of the hormones to be studied, e.g. infectious diseases, renal or hepatic failure, type 1 or type 2 diabetes mellitus, cancer or lymphoma, hypogonadism, malabsorption or malnourishment, hypo- or hyperthyroidism, hypercortisolism, alcoholism or drug abuse, anemia, or eating disorder
  • On medications known to affect the hormones to be measured (glucocorticoids, anti-seizure medications, and thyroid hormones)
  • A known history of anaphylaxis or anaphylactoid-like reactions, or a known hypersensitivity to E. coli derived proteins

Key Trial Info

Start Date :

October 1 2002

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

December 1 2016

Estimated Enrollment :

13 Patients enrolled

Trial Details

Trial ID

NCT00140231

Start Date

October 1 2002

End Date

December 1 2016

Last Update

June 7 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Beth Israel Deaconess Medical Center

Boston, Massachusetts, United States, 02215